BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15801967)

  • 1. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H; Brand A
    Br J Haematol; 2005 Apr; 129(1):151-6. PubMed ID: 15801967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
    Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
    Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review.
    Cheng CK; Lee CK; Lin CK
    Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis.
    Shukla JS; Chaudhary RK
    Indian J Pathol Microbiol; 1999 Jul; 42(3):299-302. PubMed ID: 10862287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.
    Papay P; Hackner K; Vogelsang H; Novacek G; Primas C; Reinisch W; Eser A; Mikulits A; Mayr WR; Körmöczi GF
    Am J Med; 2012 Jul; 125(7):717.e1-8. PubMed ID: 22560809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressants and alloimmunization against red blood cell transfusions.
    Zalpuri S; Evers D; Zwaginga JJ; Schonewille H; de Vooght KM; le Cessie S; van der Bom JG
    Transfusion; 2014 Aug; 54(8):1981-7. PubMed ID: 24689865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS; Roberts K; Hawthorne LM; McCaskill DM; Veillon DM; Caldito GC; Cotelingam JD
    Ann N Y Acad Sci; 2005; 1054():495-9. PubMed ID: 16339705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H; van de Watering LM; Brand A
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alloimmunization in polytransfused patients. Usefulness of selecting erythrocytes compatible with antigens different from ABO and D].
    García Gala JM; Vargas Pabon M; Rodríguez Vicente P; Ramírez Payer A; Rosón Porto C; Corte Buelga JR
    Sangre (Barc); 1994 Dec; 39(6):417-21. PubMed ID: 7855692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
    Natukunda B; Schonewille H; van de Watering L; Brand A
    Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.